Uncategorized

Otsuka’s drug eases symptom burden, anxiety in ADHD as FDA verdict nears

Published

on

The positive ADHD data for Otsuka Pharmaceutical’s centanafadine is good news in what has of late been a mixed bag for the neuropsychiatric space.

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version